MedTrace Logo

Safety and Efficacy of Non-ablative Er:YAG Laser Therapy for the Treatment of Pelvic Organ Prolapse and Coexisting Stress Urinary Incontinence: A Retrospective Case Series.

NCT04417413 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2020-11-13

No results posted yet for this study

Summary

The objective of the study is to retrospectively collect the data on patients who underwent pelvic organ prolapse treatment using a non-ablative Er:YAG laser with SMOOTH mode and to conduct an objective evaluation of safety and efficacy of Er:YAG laser treatment. In a group of patients that have concomitant stress urinary incontinence symptoms, the effectiveness of the treatments on these symptoms will be evaluated as well.

Conditions

  • Cystocele
  • Pelvic Organ Prolapse
  • Stress Urinary Incontinence

Interventions

DEVICE

Fotona ProlapLase

Non-ablative SMOOTH mode intravaginal Er:YAG teratment for pelvic organ prolapse

Sponsors & Collaborators

  • Aleksandra Novakov Mikic

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Serbia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04417413 on ClinicalTrials.gov